Rankings
▼
Calendar
RAPT Q3 2025 Earnings — RAPT Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
RAPT
RAPT Therapeutics, Inc.
$959M
Q3 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$19M
Net Income
-$18M
EPS (Diluted)
$-0.65
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$12M
Free Cash Flow
-$12M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$166M
Total Liabilities
$14M
Stockholders' Equity
$152M
Cash & Equivalents
$38M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$19M
-$20M
+2.1%
Net Income
-$18M
-$18M
+4.6%
← Q2 2025
All Quarters